Published in Am J Hypertens on August 16, 2012
The effect of acute maximal exercise on postexercise hemodynamics and central arterial stiffness in obese and normal-weight individuals. Physiol Rep (2017) 1.39
Baroreflex dysfunction and augmented sympathetic nerve responses during mental stress in veterans with post-traumatic stress disorder. J Physiol (2017) 0.88
Factors associated with blood pressure response to the cold pressor test: the GenSalt Study. Am J Hypertens (2013) 0.81
Cardiovascular response to thermoregulatory challenges. Am J Physiol Heart Circ Physiol (2015) 0.79
Cardiovascular response to acute cold stress in non-obese and obese healthy adults. Ethiop J Health Sci (2015) 0.75
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Years of life lost due to obesity. JAMA (2003) 12.18
Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res (1985) 3.88
General characteristics of sympathetic activity in human muscle nerves. Acta Physiol Scand (1972) 3.12
Manoeuvres affecting sympathetic outflow in human muscle nerves. Acta Physiol Scand (1972) 3.07
Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med (1987) 2.82
Cardiovascular reactivity and development of preclinical and clinical disease states. Psychosom Med (2003) 2.69
Effects of the cold pressor test on muscle sympathetic nerve activity in humans. Hypertension (1987) 2.46
Midlife body mass index and hospitalization and mortality in older age. JAMA (2006) 2.36
Sympathetic neural activation in visceral obesity. Circulation (2002) 2.34
Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol (1992) 1.97
Exaggerated sympathetic and pressor responses to handgrip exercise in older hypertensive humans: role of the muscle metaboreflex. Am J Physiol Heart Circ Physiol (2010) 1.90
Cold pressor test as a predictor of hypertension. Hypertension (1984) 1.77
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension (2007) 1.71
Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol (1996) 1.54
Regulation of muscle sympathetic nerve activity during exercise in humans. Exerc Sport Sci Rev (1991) 1.43
Effects of hypertension and obesity on the sympathetic activation of heart failure patients. Hypertension (2003) 1.42
Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension (2004) 1.42
Cardiovascular reactivity to stress predicts future blood pressure status. Hypertension (1993) 1.40
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens (2004) 1.38
Augmented sympathetic nerve activity in response to stressors in young borderline hypertensive men. Acta Physiol Scand (1991) 1.29
Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension (2000) 1.28
Cardiovascular reactivity to stress predicts future blood pressure in adolescence. Psychosom Med (2003) 1.26
Impaired cardiovascular recovery following stress predicts 3-year increases in blood pressure. J Hypertens (2005) 1.24
Microneurography as a tool in clinical neurophysiology to investigate peripheral neural traffic in humans. Clin Neurophysiol (2006) 1.21
Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens (2007) 1.12
Renal sympathetic nerve activity is increased in obese Zucker rats. Hypertension (1995) 1.06
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension (2005) 1.06
Normotensive blacks have heightened sympathetic response to cold pressor test. Hypertension (1993) 1.05
Overweight and sympathetic overactivity in black Americans. Hypertension (2001) 1.04
Race, family history of hypertension, and sympathetic response to cold pressor testing. Blood Press (1997) 1.04
Abnormal neurovascular control during sympathoexcitation in obesity. Obes Res (2003) 1.02
Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. Am J Physiol (1996) 1.02
Muscle metaboreflex control is diminished in normotensive obese women. Am J Physiol Heart Circ Physiol (2001) 1.01
Plasma norepinephrine and muscle sympathetic discharge during rhythmic exercise in humans. J Appl Physiol (1985) (1988) 0.97
The neurobiology of human obesity. Exp Physiol (2005) 0.94
Exercise pressor reflex in humans with end-stage renal disease. Am J Physiol Regul Integr Comp Physiol (2008) 0.88
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation. Clin Exp Pharmacol Physiol (1999) 0.81
Obesity and the sympathetic nervous system. Blood Press Suppl (1996) 0.78
The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J Am Coll Cardiol (2003) 2.52
A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis (2003) 1.63
Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol (2008) 1.47
COUNTERPOINT: Does the Risk of Electronic Cigarettes Exceed Potential Benefits? No. Chest (2015) 1.42
Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol. Eur J Heart Fail (2007) 1.20
Effects of exercise training in patients with chronic heart failure and sleep apnea. Sleep (2009) 1.14
Adaptations in autonomic function during exercise training in heart failure. Heart Fail Rev (2008) 1.13
A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3. J Am Coll Cardiol (2015) 1.08
Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension (2006) 1.08
Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens (2002) 1.07
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol (2013) 1.05
Signal-averaged electrocardiogram in Ebstein's anomaly. Am J Cardiol (2004) 1.04
Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension (2002) 1.04
Effects of long-term exercise training on autonomic control in myocardial infarction patients. Hypertension (2011) 1.03
Altered pattern of sympathetic activity with the ovarian cycle in female smokers. Am J Physiol Heart Circ Physiol (2009) 1.02
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function. Am J Kidney Dis (2005) 1.01
Lixivaptan: a novel vasopressin receptor antagonist. Expert Opin Investig Drugs (2009) 1.01
Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. J Appl Physiol (1985) (2008) 0.96
Exercise training improves aortic depressor nerve sensitivity in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol (2006) 0.94
Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. Am J Kidney Dis (2005) 0.93
Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients. J Card Fail (2004) 0.92
Exercise training in heart failure: reduction in angiotensin II, sympathetic nerve activity, and baroreflex control. J Appl Physiol (1985) (2008) 0.91
Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension. Am J Hypertens (2002) 0.90
Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases. Am J Kidney Dis (2010) 0.89
Exercise pressor reflex in humans with end-stage renal disease. Am J Physiol Regul Integr Comp Physiol (2008) 0.88
IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA. Clin Nephrol (2012) 0.87
Chronic renal injury-induced hypertension alters renal NHE3 distribution and abundance. Am J Physiol Renal Physiol (2003) 0.85
Impact of gender on benefits of exercise training on sympathetic nerve activity and muscle blood flow in heart failure. Eur J Heart Fail (2010) 0.85
Mechanisms of blunted muscle vasodilation during peripheral chemoreceptor stimulation in heart failure patients. Hypertension (2012) 0.85
Regional expression of NAD(P)H oxidase and superoxide dismutase in the brain of rats with neurogenic hypertension. Am J Nephrol (2008) 0.83
Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial. J Card Fail (2011) 0.83
Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects. Am J Hypertens (2006) 0.83
Sympathetic nerve activity restrains reflex vasodilatation in heart failure. Clin Auton Res (2007) 0.82
Effects of exercise training on neurovascular responses during handgrip exercise in heart failure patients. Int J Cardiol (2010) 0.82
Exercise training improves neurovascular control and functional capacity in heart failure patients regardless of age. Eur J Prev Cardiol (2011) 0.82
Muscle sympathetic nerve activity in patients with Chagas' disease. Int J Cardiol (2008) 0.81
Exercise pressor response and arterial baroreflex unloading during exercise in chronic kidney disease. J Appl Physiol (1985) (2012) 0.81
Adverse drug responses: An increasing threat to the well-being of older patients: Comment on "Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older". Arch Intern Med (2010) 0.81
Statin use in patients with diabetes and kidney disease: the Japanese experience. J Atheroscler Thromb (2013) 0.80
Responses of proximal tubule sodium transporters to acute injury-induced hypertension. Am J Physiol Renal Physiol (2002) 0.80
Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure. Am J Physiol Heart Circ Physiol (2007) 0.80
Cigarette smoking is associated with dose-dependent adverse effects on paraoxonase activity and fibrinogen in young women. Inhal Toxicol (2014) 0.79
HMG-CoA reductase inhibitors and renal function. Clin J Am Soc Nephrol (2007) 0.79
Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up. Nutr Metab Cardiovasc Dis (2007) 0.78
Aldosterone and hypertension in African Americans. Am J Hypertens (2009) 0.78
Aldosterone in the pathogenesis of chronic kidney disease and proteinuria. Curr Hypertens Rep (2010) 0.78
Sympathetic activation restrains endothelium-mediated muscle vasodilatation in heart failure patients. Am J Physiol Heart Circ Physiol (2005) 0.78
Potential autonomic nervous system effects of statins in heart failure. Heart Fail Clin (2008) 0.78
Angiotensin receptor blocker telmisartan improves insulin sensitivity in peritoneal dialysis patients. Perit Dial Int (2010) 0.77
Use of antagonists of aldosterone in patients with chronic kidney disease: Potential advantages and risks. J Hypertens (2006) 0.77
Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children. Pediatr Nephrol (2009) 0.77
Resistant hypertension and obstructive sleep apnea in end-stage renal disease. J Hypertens (2012) 0.76
Rebuttal From Dr Middlekauff. Chest (2015) 0.75
Antihypertensive drugs and the kidney. Curr Cardiol Rep (2004) 0.75
Evolving role of calcium antagonists in the management of hypertension. Med Clin North Am (2004) 0.75
ACE inhibitors: over two decades of use. J Clin Hypertens (Greenwich) (2005) 0.75